InnoPharmax
About
About Us
Organization
Our History
News
News
Technologies
OralPAS®
OralPAS Pro®
MUCR™
R&D
Pipeline
D07001 GemOral
D0191801 Oral Insulin
D0282102 Bendamustine RTD
Products
Anti-infection Agents
Contrast Agents
Oncology Agents
Immunological Agents
Drugs for Rare Diseases
Active Pharmaceutical Ingredient
Investors
Financial Information
Company Profile
Monthly Revenue
Financial Statements
Corporate Governance
Board Meeting
Committee
Internal Audit
Rule of Procedure
Corporate Social Responsibility
Shareholders Services
Annual Reports
Shareholders' Meetings
Announcements
Contact
Contacts
Contact Information
Career Opportunities
ZH-TW
Investor Relations
Financial Information
Company Profile
Monthly Revenue
Financial Statements
Corporate Governance
Board Meeting
Committee
Internal Audit
Rule of Procedure
Corporate Social Responsibility
Shareholders Services
Annual Reports
Shareholders' Meetings
Announcements
Contact
Corporate Social Responsibility
>
Corporate Governance
>
Investor Relation
>
home
Corporate Social Responsibility
2019 CSR Report
2018 CSR Report
2017 CSR Report
2016 CSR Report
2015 CSR Report
2014 CSR Report
2013 CSR Report
2012 CSR Report
CSR Policy
uGear Design
-
Website Info.
